Penn researchers develop bioengineered chewing gum with potential to prevent oral and head cancers
By
Nicole Leonard
Crackling crust, pillowy middle. The kind of bagel that earns a second cup of coffee.
Summary
Researchers at Penn, led by Dr. Henry Daniell, have developed a bioengineered chewing gum made from a bean plant that contains antiviral, antibacterial, and antifungal properties. The gum is being tested against HPV, influenza, and other diseases, with the goal of potentially helping prevent oral, head, and neck cancers. The gum is flavored with mint and shows promise as a novel delivery method for therapeutic agents.
Key quotes
· 3 pulledIt has been flavored
Researcher Dr. Henry Daniell picked up a small, black canister from his office desk and unscrewed the lid. Inside were about two dozen dime-sized white tablets of gum encased in a crunchy outer shell.
A strong smell of mint emanated from the can.
You might also wanna read
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha

Startup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f

Startup Bexorg uses intact postmortem human brains for neurodegenerative drug testing
A startup called Bexorg is using intact brains from deceased human donors to test drugs for neurodegenerative diseases. By restoring blood f
Personalized mRNA Cancer Vaccine Shows 49% Risk Reduction at 5-Year Follow-up
Moderna and Merck report promising 5-year follow-up results for their personalized mRNA cancer vaccine combined with Keytruda immunotherapy.
arstechnica.com·4mo agoCompany Develops Magnetically Controlled Antibody for Targeted Drug Delivery
A company called Nonfiction Labs has developed a remote-controlled antibody that can be turned on and off using a magnet. This breakthrough
